Oncternal Therapeutics Inc (ONCT)

Oncternal Therapeutics Inc Azioni (ONCT) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	91.58% 0.569	0.297	0.179	0.106	0.203
Operating Expenses	5.89% 9.348	9.933	10.57	9.651	12.35
Benefits Costs and Expenses	5.33% 8.957	9.461	-	-	11.69
Costs And Expenses	5.33% 8.957	9.461	10.57	9.651	11.69
Operating Income/Loss	8.89% -8.779	-9.636	-10.39	-9.545	-12.14
Income/Loss From Continuing Operations Before Tax	8.47% -8.388	-9.164	0.179	0.106	-11.49
Income/Loss From Continuing Operations After Tax	8.47% -8.388	-9.164	-9.862	-8.966	-11.49
Net Income/Loss	8.47% -8.388	-9.164	-9.862	-8.966	-11.49
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	105.30% 2.959	-55.80	58.96	58.72	58.52
Diluted Average Shares	105.30% 2.959	-55.80	58.96	58.72	58.52
Basic Earnings Per Share	78.08% -2.83	-12.91	-0.17	-0.15	-0.20
Diluted Earnings Per Share	78.08% -2.83	-12.91	-0.17	-0.15	-0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-